{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:19:53Z","timestamp":1793834393058,"version":"4.6.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1136\/ijgc-2020-001860","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T17:10:31Z","timestamp":1603818631000},"page":"1990-1996","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Transgender patients: considerations for routine gynecologic care and cancer screening"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1909-8848","authenticated-orcid":false,"given":"Trinidad","family":"Labanca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Ma\u00f1ero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Pannunzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2020-001860_bb0010","first-page":"e42","article-title":"Committee opinion no 706: sexual health","volume":"130","author":"Committee on Gynecologic Practice","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001860_bb0015","author":"WHO","year":"2018","journal-title":"Defining sexual health"},{"key":"10.1136\/ijgc-2020-001860_bb0020","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-018121","article-title":"Cohort profile: study of transition, outcomes and gender (strong) to assess health status of transgender people","volume":"7","author":"Quinn","year":"2017","journal-title":"BMJ Open"},{"key":"10.1136\/ijgc-2020-001860_bb0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1056\/NEJMcp1903650","article-title":"Care of transgender persons","volume":"381","author":"Safer","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2020-001860_bb0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(16)00684-X","article-title":"Global health burden and needs of transgender populations: a review","volume":"388","author":"Reisner","year":"2016","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2020-001860_bb0035","unstructured":"J Feldman , MBDeutsch . Primary care of transgender individuals. Available: https:\/\/www.uptodate.com\/contents\/primary-care-of-transgender-individuals [Accessed 20 Nov 2020]."},{"key":"10.1136\/ijgc-2020-001860_bb0040","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"10.1136\/ijgc-2020-001860_bb0045","unstructured":"MP Schneider , WPBockting, RPEhrbar, et al . APA task force on gender identity and gender variance. Available: https:\/\/www.apa.org\/news\/press\/releases\/gender-variant-2.pdf [Accessed 21 Jun 2020]."},{"key":"10.1136\/ijgc-2020-001860_bb0050","author":"American Psychiatric Association","year":"2013"},{"key":"10.1136\/ijgc-2020-001860_bb0055","doi-asserted-by":"crossref","DOI":"10.1186\/s12914-018-0155-5","article-title":"Bibliometric analysis of peer-reviewed literature in transgender health (1900 - 2017)","volume":"18","author":"Sweileh","year":"2018","journal-title":"BMC Int Health Hum Rights"},{"key":"10.1136\/ijgc-2020-001860_bb0060","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1213\/ANE.0000000000003371","article-title":"The perioperative care of the transgender patient","volume":"127","author":"Tollinche","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1136\/ijgc-2020-001860_bb0065","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ijgc-2020-001860_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.gore.2017.03.010","article-title":"Vulvar condylomatosis after sex reassignment surgery in a male-to-female transsexual: complete response to imiquimod cream","volume":"20","author":"Labanca","year":"2017","journal-title":"Gynecol Oncol Rep"},{"key":"10.1136\/ijgc-2020-001860_bb0075","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/2000656X.2014.967253","article-title":"Male-6o-female vaginoplasty: Preecha's surgical technique","volume":"49","author":"Wangjiraniran","year":"2015","journal-title":"J Plast Surg Hand Surg"},{"key":"10.1136\/ijgc-2020-001860_bb0080","article-title":"Aesthetic refinements after radial free flap phalloplasty: optimizing the donor site and the phallus","volume":"5","author":"Ma\u00f1ero","year":"2017","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"10.1136\/ijgc-2020-001860_bb0085","first-page":"e11","article-title":"Committee opinion no. 685: care for transgender adolescents","volume":"129","author":"Committee on Adolescent Health Care","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001860_bb0090","doi-asserted-by":"crossref","DOI":"10.1177\/2042018819871166","article-title":"Health considerations for transgender women and remaining unknowns: a narrative review","volume":"10","author":"Iwamoto","year":"2019","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1136\/ijgc-2020-001860_bb0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1089\/jwh.2014.4918","article-title":"Care of the transgender patient: a survey of gynecologists' current knowledge and practice","volume":"24","author":"Unger","year":"2015","journal-title":"J Womens Health"},{"key":"10.1136\/ijgc-2020-001860_bb0100","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1007\/s11606-015-3462-8","article-title":"Cervical cancer screening for patients on the female-to-male spectrum: a narrative review and guide for clinicians","volume":"30","author":"Potter","year":"2015","journal-title":"J Gen Intern Med"},{"key":"10.1136\/ijgc-2020-001860_bb0105","first-page":"1-137","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Centers for Disease Control and Prevention","year":"2015","journal-title":"MMWR Recomm Rep"},{"key":"10.1136\/ijgc-2020-001860_bb0110","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1111\/1471-0528.15258","article-title":"Breast and reproductive cancers in the transgender population: a systematic review","volume":"125","author":"Joint","year":"2018","journal-title":"BJOG"},{"key":"10.1136\/ijgc-2020-001860_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1002\/jgc4.1278","article-title":"Unanswered questions: hereditary breast and gynecological cancer risk assessment in transgender adolescents and young adults","volume":"29","author":"Sutherland","year":"2020","journal-title":"J Genet Couns"},{"key":"10.1136\/ijgc-2020-001860_bb0120","author":"NCCN","year":"2020","journal-title":"National comprehensive cancer network (NCCN) clinical practice guidelines in oncology: breast cancer version 5.2020. National comprehensive cancer network"},{"key":"10.1136\/ijgc-2020-001860_bb0125","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1111\/jsm.12319","article-title":"Breast cancer development in transsexual subjects receiving cross-sex hormone treatment","volume":"10","author":"Gooren","year":"2013","journal-title":"J Sex Med"},{"key":"10.1136\/ijgc-2020-001860_bb0130","article-title":"Breast cancer risk in transgender people receiving hormone treatment: nationwide cohort study in the Netherlands","volume":"365","author":"de Blok","year":"2019","journal-title":"BMJ"},{"key":"10.1136\/ijgc-2020-001860_bb0135","doi-asserted-by":"crossref","first-page":"E598","DOI":"10.9778\/cmajo.20180028","article-title":"Breast cancer risk and breast screening for trans people: an integration of 3 systematic reviews","volume":"7","author":"Meggetto","year":"2019","journal-title":"CMAJ Open"},{"key":"10.1136\/ijgc-2020-001860_bb0140","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/jsm.12628","article-title":"Hormonal and surgical treatment in trans-women with BRCA1 mutations: a controversial topic","volume":"11","author":"Colebunders","year":"2014","journal-title":"J Sex Med"},{"key":"10.1136\/ijgc-2020-001860_bb0145","unstructured":"V Tangpricha , JDSafer . Transgender women: evaluation and management - UpToDate. Available: https:\/\/www.uptodate.com\/contents\/transgender-women-evaluation-and-management [Accessed 21 Jun 2020]."},{"key":"10.1136\/ijgc-2020-001860_bb0150","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1016\/j.jpedsurg.2010.05.016","article-title":"Vaginal replacement in the pediatric age group: a 34-year experience of intestinal vaginoplasty in children and young girls","volume":"45","author":"Lima","year":"2010","journal-title":"J Pediatr Surg"},{"key":"10.1136\/ijgc-2020-001860_bb0155","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0956462414542476","article-title":"Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod","volume":"26","author":"Matsuki","year":"2015","journal-title":"Int J STD AIDS"},{"key":"10.1136\/ijgc-2020-001860_bb0160","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1158\/1055-9965.EPI-06-0997","article-title":"Human papillomavirus prevalence and type distribution in male anogenital sites and semen","volume":"16","author":"Nielson","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1136\/ijgc-2020-001860_bb0165","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/infdis\/jiu587","article-title":"Human papillomavirus virus (HPV) genotype- and age-specific analyses of external genital lesions among men in the HPV infection in men (HIM) study","volume":"211","author":"Ingles","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1136\/ijgc-2020-001860_bb0170","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.ajog.2010.12.057","article-title":"Gynecologic malignancies in female-to-male transgender patients: the need of original gender surveillance","volume":"204","author":"Urban","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1136\/ijgc-2020-001860_bb0175","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/epirev\/mxw003","article-title":"Cancer in transgender people: evidence and methodological considerations","volume":"39","author":"Braun","year":"2017","journal-title":"Epidemiol Rev"},{"key":"10.1136\/ijgc-2020-001860_bb0180","unstructured":"V Tangpricha , JDSafer . Transgender men: evaluation and management. Available: https:\/\/www.uptodate.com\/contents\/transgender-men-evaluation-and-management [Accessed 21 Jun 2020]."},{"key":"10.1136\/ijgc-2020-001860_bb0185","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement","volume":"164","author":"U.S. Preventive Services Task Force","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1136\/ijgc-2020-001860_bb0190","unstructured":"ACOG . Health care for transgender individuals. Available: https:\/\/www.acog.org\/clinical\/clinical-guidance\/committee-opinion\/articles\/2011\/12\/health-care-for-transgender-individuals [Accessed 21 Jun 2020]."},{"key":"10.1136\/ijgc-2020-001860_bb0195","unstructured":"Screening in LGBTQ communities - Canadian Cancer Society [Internet] . Available: https:\/\/www.cancer.ca\/en\/prevention-and-screening\/reduce-cancer-risk\/find-cancer-early\/screening-in-lgbtq-communities\/?region=on [Accessed 20 Nov 2020]."},{"key":"10.1136\/ijgc-2020-001860_bb0200","first-page":"147","article-title":"American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer","volume":"62","author":"Saslow","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"10.1136\/ijgc-2020-001860_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190172","article-title":"Test performance and acceptability of self- versus provider-collected swabs for high-risk HPV DNA testing in female-to-male trans masculine patients","volume":"13","author":"Reisner","year":"2018","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2020-001860_bb0210","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/j.1365-2559.1986.tb02520.x","article-title":"Histological changes in the genital tract in transsexual women following androgen therapy","volume":"10","author":"Miller","year":"1986","journal-title":"Histopathology"},{"key":"10.1136\/ijgc-2020-001860_bb0215","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1089\/trgh.2019.0037","article-title":"Do transgender and gender diverse individuals receive adequate gynecologic care? An analysis of a rural academic center","volume":"5","author":"Stewart","year":"2020","journal-title":"Transgend Health"},{"key":"10.1136\/ijgc-2020-001860_bb0220","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0020-7292(03)00278-9","article-title":"ACOG Committee opinion. routine cancer screening. number 247, December 2000","volume":"82","author":"ACOG committee","year":"2003","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1136\/ijgc-2020-001860_bb0225","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000094097","article-title":"Ovarian cancer associated with testosterone supplementation in a female-to-male transsexual patient","volume":"62","author":"Dizon","year":"2006","journal-title":"Gynecol Obstet Invest"},{"key":"10.1136\/ijgc-2020-001860_bb0230","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1006\/gyno.1999.5720","article-title":"Ovarian cancer in female-to-male transsexuals: report of two cases","volume":"76","author":"Hage","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2020-001860_bb0235","doi-asserted-by":"crossref","first-page":"e3293","DOI":"10.1210\/clinem\/dgaa412","article-title":"Prostate cancer incidence under androgen deprivation: nationwide cohort study in trans women receiving hormone treatment","volume":"105","author":"de Nie","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1136\/ijgc-2020-001860_bb0240","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/and.12208","article-title":"Prostate cancer incidence in orchidectomised male-to-female transsexual persons treated with oestrogens","volume":"46","author":"Gooren","year":"2014","journal-title":"Andrologia"},{"key":"10.1136\/ijgc-2020-001860_bb0245","doi-asserted-by":"crossref","DOI":"10.1046\/j.1464-410x.1998.00582.x","article-title":"Metastatic prostatic carcinoma in a male-to-female transsexual","volume":"81","author":"van Haarst","year":"1998","journal-title":"Br J Urol"},{"key":"10.1136\/ijgc-2020-001860_bb0250","first-page":"35","article-title":"Gynaecological aspects of the treatment and follow-up of transsexual men and women","volume":"2","author":"Weyers","year":"2010","journal-title":"Facts Views Vis Obgyn"},{"key":"10.1136\/ijgc-2020-001860_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(15)00249-1","article-title":"Cancer risk in the transgender community","volume":"16","author":"The Lancet Oncology","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24012489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24012489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2020-001860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:25:19Z","timestamp":1753233919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24012489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1048891X24012489"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2020-001860","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transgender patients: considerations for routine gynecologic care and cancer screening","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2020-001860","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}